UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of November, 2014
 
Commission File Number 000-28996

ELBIT IMAGING LTD.
  (Translation of Registrant’s Name into English)
 
5 KINNERET STREET, BNEI BRAK, ISRAEL
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F x Form 40-F o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
 
 
 

 

EXHIBIT 99.1 OF THIS REPORT ON FORM 6-K IS HEREBY INCORPORATED BY REFERENCE INTO ELBIT IMAGING LTD.’S REGISTRATION STATEMENT ON FORM F-3 (REGISTRATION STATEMENT NO. 333-172122) AND REGISTRATION STATEMENTS ON FORM S-8 (REGISTRATION STATEMENTS NOS. 333-117509, 333-130852, 333-136684 AND 333-152820), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.
 
CONTENTS
 
This Report on Form 6-K of Elbit consists of the following document, which is attached hereto and incorporated by reference herein:
 
99.1.
Press Release: ELBIT IMAGING LTD. ANNOUNCES THIRD QUARTER RESULTS FOR 2014.
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
Date: November 25, 2014
 
ELBIT IMAGING LTD.
(Registrant)
 
By: /s/ Ron Hadassi
——————————————
Ron Hadassi
Chairman of the Board of Directors

 
2

 
 
EXHIBIT INDEX
 
EXHIBIT NO.
DESCRIPTION
   
99.1.
Press Release: ELBIT IMAGING LTD. ANNOUNCES THIRD QUARTER RESULTS FOR 2014.
 
3







Exhibit 99.1
 
ELBIT IMAGING LTD. ANNOUNCES THIRD QUARTER RESULTS FOR 2014

Tel Aviv, Israel, November 25, 2014, Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit"" or the "Company") announced today its results for the third quarter of 2014.

Three months ended September 30, 2014 compared to corresponding period in 2013

The Company’s loss for the three months period ended September 30, 2014 (“Q3 2014”) amounted to NIS 32 million.
 
Consolidated income, revenues and gain for Q3 2014 amounted to NIS 318 million (US$ 86 million) compared to NIS 120 million in the corresponding period in 2013 (“Q3 2013”).
 
·
Revenues from sale of commercial centers increased in Q3 2014 to NIS 196 (US$ 53 million) compared to NIS 9 million in Q3 2013. Such amount in Q3 2014 is attributable to the sale of commercial centers by our 62% subsidiary Plaza Centers N.V. ("PC") in Serbia and sale of plot in Romania.
 
·
Rental income from commercial centers amounted to NIS 28 million (US$ 8 million) in Q3 2014 and in Q3 2013.
 
·
Cost of commercial centers increased in Q3 2014 to NIS 217 million (US$ 59 million) compared to NIS 39 million in Q3 2013. The increase is mainly attributable to (i) cost of commercial centers and plots sold by PC during Q3 2014 in the amount of NIS 198 million (US$ 54 million) compared to NIS 10 million in Q3 2013 offset by: (ii) decrease in PC's general and administrative expenses as a result of efficiency measures taken by PC during 2014.
 
·
Revenues from hotels operation and management increased in Q3 2014 to NIS 49 million (US$ 13 million) compared to NIS 47 million in Q3 2013.
 
·
Costs and expenses of hotels operation and management increased in Q3 2014 to NIS 42 million (US$ 11 million) compared to NIS 41 million in Q3 2013.
 
·
Revenues from fashion merchandise decreased in Q3 2014 to NIS 33 million (US$ 9 million) compared to NIS 36 million in Q3 2013. The decrease is attributable to the Israeli military operation in Gaza during Q3 and to the closing of three Mango stores compared to the opening of two new stores.
 
·
Cost of fashion retail increased in Q3 2014 to NIS 37 million (US$ 10 million) compared to NIS 35 million in Q3 2013.
 
·
Gain from change of shareholding in investees amounted to NIS 11 million (US$ 3 million) in Q3 2014 compared to nil in Q3 2013. This gain is attributable to decreased in our holdings in Gamida Cell Ltd, as a result of the consummation of an investment and option agreement with Novartis Pharmaceuticals Corporation.
 
 
 

 
 
·
General and administrative expenses amounted to NIS 8 million (US$ 2 million) in Q3 2014 compared to NIS 13 million in Q3 2013. The decrease in mainly attributable to the Company's arrangement costs in Q3 2013 as well as efficiency measures taken by the Company reducing the general and administrative costs in the Company’s headquarters.
 
·
Share in losses of associated, net amounted to NIS 10 million (US$ 3 million) in Q3 2014 compared to NIS 288 in Q3 2013. Such losses in Q3 2014 are mainly attributable to the Company's medical device investments. The losses in Q3 2013 are mainly attributable to impairment of trading property by an associated company in India.
 
·
Financial expenses, net decreased in Q3 2014 to NIS 51 million (US$ 14 million) compared to NIS 188 million in Q3 2013. The decrease of NIS 137 million (US$ 37 million) is mainly attributable to the following:
 
 
o
A decrease in the amount of NIS 90 million (US$ 24 million) in non-cash expenses, as a result of changes in fair value of financial instruments (mainly PC’s debentures and other derivatives), which are measured at fair value through profit and loss.
 
 
o
A decrease in interest expenses and CPI-linked borrowing expenses, net in the amount of NIS 67 million (US$ 18 million) mainly attributable to (i) decrease in the Company interest net mainly due to the lower level of the Company's Corporate debts following the consummation of the Company's debt restructuring; and (ii) a decrease in the Israeli consumer price index, to which the Company’s and several of PC’s notes are linked (0.29% in Q3 2014, compared to 1.29% in Q3 2013).
 
Offset by:
 
 
o
An increase in the amount of NIS 20 million (US$ 5 million) in exchange rate losses mainly attributable to fluctuation in the exchange rate between the US$ and NIS with respect to the Company’s loan from Israeli banks.
 
·
Other income, net in Q3 2014 amounted to NIS 15 million (US$ 4 million) compared to expenses in the amount of NIS 254 million in Q3 2013. The income in Q3 2014 is attributable to realization of revelation reserve to the profit and loss account as a result of the sale of Park Plaza shares held by the Company.
 
·
Loss before tax benefits amounted to NIS 33 million (US$ 9 million) in Q3 2014 compared to NIS 738 million in Q3 2013.
 
·
Tax benefits amounted to NIS 1 million (US$ 0.3 million) in Q3 2014 compared to NIS 29 million in Q3 2013.
 
·
Loss from continuing operations amounted to NIS 32 million (US$ 9 million) in Q3 2014 compared to NIS 709 million in Q3 2013.
 
·
Income from discontinued operations, net, amounted to nil in Q3 2014 compared to NIS 7 million in Q3 2013.
 
 
2

 
 
·
Loss for Q3 2014 amounted to NIS 32 million (US$ 9 million) (all attributed to the equity holders of the Company) compared to NIS 702 million in the corresponding period in 2013 (out of which NIS 523 million is attributed to the equity holders of the Company).
 
·
Shareholders' Equity as of September 30, 2014 amounted to NIS 861 million ($ 233 million) (out of which Shareholders' Equity in the amount of NIS 409 million ($ 111 million) is attributed to the controlling interest).
 
About Elbit Imaging Ltd.
 
Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, we operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.
 
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
 
Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as “believe,” "would," “expect,” “intend,” “estimate” and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the Consideration, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2013, under the caption “Risk Factors.” Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.
 
For Further Information:
 
Company Contact:
 
Ron Hadassi
 
 
Chairman of the Board of Directors Acting CEO
 
Tel: +972-3-608-6048
 
ron@elbitimaging.com
 
 
3

 
 
ELBIT IMAGING LTD.
CONSOLIDATED BALANCE SHEETS
 
   
September 30
   
December 31
   
September 30
 
   
2 0 1 4
   
2 0 1 3
   
2 0 1 4
 
               
Convenience
 
               
translation
 
   
(in NIS thousands)
   
US$'000
 
                   
Current Assets
                 
Cash and cash equivalents
    300,365       311,181       81,290  
Short-term deposits and investments
    94,534       82,157       25,584  
Trade accounts receivables
    90,219       38,498       24,416  
Other receivables
    38,963       47,330       10,545  
Inventories
    34,680       22,315       9,386  
Trading property
    -       192,867       -  
      558,761       694,348       151,221  
                         
Non-Current Assets
                       
Trading property
    1,962,048       2,380,039       531,001  
Deposits, loans and other long-term balances
    31,834       47,782       8,616  
Investments in associates
    331,874       333,440       89,817  
Property, plant and equipment
    1,056,371       1,108,835       285,891  
      3,382,127       3,870,096       915,325  
      3,940,888       4,564,444       1,066,546  
                         
Current Liabilities
                       
Short-term credits
    1,585,720       4,464,373       429,153  
Suppliers and service providers
    44,618       43,680       12,075  
Payables and other credit balances
    160,410       286,424       43,413  
      1,790,748       4,794,477       484,641  
                         
Non-Current liabilities
                       
Borrowings
    1,098,408       -       297,269  
Other liabilities
    103,264       93,466       27,947  
Deferred taxes
    87,033       85,131       23,554  
      1,288,705       178,597       348,770  
                         
Shareholders' Equity (Deficiency)
                       
Attributable to equity holders of the Company
    410,339       (1,032,637 )     111,052  
Non-controlling Interests
    451,096       624,007       122,083  
      861,435       (408,630 )     233,135  
      3,940,888       4,564,444       1,066,546  
 
 
4

 
 
ELBIT IMAGING LTD.
CONSOLIDATED INCOME STATEMENTS
 
   
Nine months ended
   
Three months ended
   
Year ended
   
Nine months ended
 
   
September 30
   
September 30
   
December 31,
   
September 30
 
   
2 0 1 4
   
2 0 1 3
   
2 0 1 4
   
2 0 1 3
   
2 0 1 3
   
2 0 1 4
 
   
(in NIS thousands)
   
Convenience
 
                                 
translation
 
                                 
US$'000
 
Income revenues and gains
                                   
Revenues
                                   
Revenues from sale of commercial centers
    195,635       8,614       195,635       8,614       8,614       52,946  
Revenues from hotel operation and management
    146,253       149,364       49,505       46,794       202,791       39,581  
Revenues from fashion merchandise
    115,252       101,548       33,296       35,735       149,192       31,191  
Total revenues
    457,140       259,526       278,436       91,143       360,597       123,718  
                                                 
Gains and other
                                               
Rental income from Commercial centers
    87,896       97,522       27,962       28,530       129,748       23,788  
                                                 
Gain from changes of shareholding in investees
    11,301       -       11,301       -       -       3,058  
                                                 
Total gains
    99,197       97,522       39,263       28,530       129,748       26,846  
Total income revenues and gains
    556,337       357,048       317,699       119,673       490,345       150,564  
                                                 
Expenses and losses
                                               
Hotels operations and management
    127,548       133,701       42,280       41,235       179,137       34,519  
Cost of fashion merchandise
    113,805       99,343       36,704       34,575       142,417       30,800  
Commercial centers
    262,168       95,945       217,408       39,402       124,737       70,952  
General and administrative expenses
    25,383       43,825       7,836       13,059       60,643       6,869  
Share in losses of associates, net
    27,389       355,043       10,086       288,158       339,030       7,414  
Financial expenses, net
    246,948       330,157       51,213       187,535       401,900       66,833  
Financial gain from debt restructuring
    (1,610,111 )     -       319       -       -       (435,752 )
Write-down, charges and other (income) expenses, net
    409,211       620,369       (14,983 )     254,125       841,462       110,746  
      (397,659 )     1,678,383       350,863       858,089       2,089,326       (107,619 )
                                                 
Profit (Loss) before income taxes
    953,996       (1,321,335 )     (33,164 )     (738,416 )     (1,598,981 )     258,183  
Tax income (benefits)
    3,369       (30,809 )     (1,062 )     (29,242 )     (31,937 )     912  
Profit (Loss) from continuing operations
    950,627       (1,290,526 )     (32,102 )     (709,174 )     (1,567,044 )     257,271  
Profit from discontinued operation, net
    -       3,485       -       6,746       2,034       -  
Profit (Loss)  for the period
    950,627       (1,287,041 )     (32,102 )     (702,428 )     (1,565,010 )     257,271  
                                                 
Attributable to:
                                               
Equity holders of the Company
    1,129,198       (955,378 )     (31,711 )     (522,789 )     (1,155,645 )     305,599  
Non-controlling interest
    (178,571 )     (331,663 )     (391 )     (179,639 )     (409,365 )     (48,328 )
      950,627       (1,287,041 )     (32,102 )     (702,428 )     (1,565,010 )     257,271  
 
 
5

 

ELBIT IMAGING LTD.
CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS
 
   
Nine months ended
   
Three months ended
   
Year ended
   
Nine months ended
 
   
September 30
   
September 30
   
December 31,
   
September 30
 
   
2 0 1 4
   
2 0 1 3
   
2 0 1 4
   
2 0 1 3
   
2 0 1 3
   
2 0 1 4
 
   
(in NIS thousands)
   
Convenience
 
                                 
translation
 
                                 
US$'000
 
                                     
Profit (Loss) for the period
    950,627       (1,287,041 )     (32,102 )     (702,428 )     (1,565,010 )     257,271  
                                                 
Other comprehensive income to be reclassified to profit or loss in subsequent periods:
                                               
                                                 
Exchange differences arising from translation of foreign operations
    6,355       (233,901 )     12,792       (29,680 )     (267,861 )     1,719  
Gain (loss) from cash flow hedge
    (783 )     4,193       (598 )     24       4,439       (212 )
Gain (loss) from available for sale investments
    (11,868 )     7,577       (17,147 )     3,755       3,545       (3,212 )
      (6,296 )     (222,131 )     (4,953 )     (25,901 )     (259,877 )     (1,705 )
Items not to be reclassified to profit or loss in subsequent periods:
                                               
Additions during the period
    (25 )     -       5,887       -       27,700       (7 )
      (25 )     -       5,887       -       27,700       (7 )
                                                 
Other Comprehensive income (loss)
    (6,321 )     (222,131 )     934       (25,902 )     (232,177 )     (1,712 )
                                                 
Comprehensive income (loss)
    944,306       (1,509,172 )     (31,168 )     (728,329 )     (1,797,187 )     255,559  
                                                 
Attributable to:
                                               
                                                 
Equity holders of the Company
    1,125,818       (1,112,545 )     (33,024 )     (540,042 )     (1,328,500 )     304,683  
Non-controlling interest
    (181,512 )     (396,627 )     1,856       (188,287 )     (468,687 )     (49,124 )
      944,306       (1,509,172 )     (31,168 )     (728,329 )     (1,797,187 )     255,559  
 
 
6

 

ELBIT IMAGING LTD.
STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

   
Share capital
   
Share premium
   
Other reserves (*)
   
Revaluation of property, plant and equipment
   
Stock-based compensation reserve
   
Foreign currency translation reserve
   
Retained earnings
   
Gross amount
   
Treasury stock
   
Attributable to share-holders of the company
   
Non Controlling interest
   
Total shareholders' equity
 
   
(in thousand NIS)
 
Balance -
January 1, 2013
    38,059       864,811       (191,698 )     190,690       49,835       (553,627 )     59,081       457,151       (168,521 )     288,629       1,100,479       1,389,108  
Loss  for the year
    -       -       -       -       -       -       (1,155,645 )     (1,155,645 )     -       (1,155,645 )     (409,365 )     (1,565,010 )
Other comprehensive income (loss)
    -       -       7,985       11,593       -       (202,257 )     9,740       (172,939 )     -       (172,939 )     (59,323 )     (232,262 )
Transaction with non-controlling interest
    -       -       1,853       -       -       -       -       1,853       -       1,853       1,106       2,959  
Reclassification of a derivative (options) following a change in terms
    -       -       -       -       -       -       -       -       -       -       (11,819 )     (11,819 )
Exercise of options by employees
    10       1,673       -       -       (1,683 )     -       -       -       -       -       -       -  
Expiration of options held by minority
    -       4,804       -       -       -       -       -       4,804       -       4,804       (4,804 )     -  
Stock-based compensation expenses
    -       -       -       -       660       -       -       660       -       660       7,734       8,394  
                                                                                                 
Balance -
December  31, 2013
    38,069       871,288       (181,862 )     202,283       48,812       (755,886 )     (1,086,820 )     (864,116 )     (168,521 )     (1,032,637 )     624,007       (408,630 )
                                                                                                 
Profit (loss)  for the period
                                                    1,129,198       1,129,198               1,129,198       (178,571 )     950,627  
Other comprehensive income (loss)
                    (12,471 )     (8,016 )             9,116       7,991       (3,380 )             (3,380 )     (2,941 )     (6,321 )
Issuance of shares
            314,220                                               314,220               314,220               314,220  
Transaction with non-controlling interest
                    2,461                                       2,461               2,461       1,515       3,976  
Treasury stock and old stock cancellation
    (38,069 )     (130,452 )                                             (168,521 )     168,521       -                  
Out of consolidation
                                                                                    2,277       2,277  
Classification
                                                                                    1,604       1,604  
Stock-based compensation expenses
                                    477                       477               477       3,205       3,682  
Balance -
September 30, 2014
    -       1,055,056       (191,872 )     194,267      
49,289
     
(746,770
)     50,369       410,339       -       410,339       451,096       861,435  
 
(*)           includes transactions with non-controlling interest reserve and hedging reserve.
 
 
7

 

ELBIT IMAGING LTD.
STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY
 
   
Share capital
   
Share premium
   
Other reserves (*)
   
Revaluation of property, plant and equipment
   
Stock-based compensation reserve
   
Foreign currency translation reserve
   
Retained earnings
   
Gross amount
   
Treasury stock
   
Attributable to share-holders of the company
   
Non Controlling interest
   
Total shareholder's equity
 
   
Convenience translation, U.S.$'000
 
Balance -
January  1, 2014
    10,303       235,802       (49,218 )     54,745       13,210       (204,570 )     (294,133 )     (233,861 )     (45,608 )     (279,469 )     168,879       (110,590 )
Profit (loss)  for the period
                                                    305,602       305,602               305,602       (48,328 )     257,274  
Other comprehensive income (loss)
                    (3,375 )     (2,169 )             2,467       2,163       (915 )             (915 )     (796 )     (1,711 )
Issuance of shares
            85,039                                               85,039               85,039       0       85,039  
Transaction with non-controlling interest
                    666                                       666               666       410       1,076  
Treasury stock and old stock cancellation
    (10,303 )     (35,305 )                                             (45,608 )     45,608                       -  
Out of consolidation
                                                            -                       616       616  
Classification
                                                                                    434       434  
Stock-based compensation expenses
                                    129                       129               129       867       996  
Balance -
September 30, 2014
    -       285,536       (51,927 )     52,576       13,339       (202,103 )     13,632       111,052       -       111,052       122,083       233,135  
 
(*)  includes transactions with non-controlling interest reserve and hedging reserve.
 
8


Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Elbit Imaging (CE) Charts.
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Elbit Imaging (CE) Charts.